ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
128.531,71
-0,02%
S&P 500
6.129,58
0,24%
US Dollar vs BRL
5,6909
0,01%
Bitcoin
0,00000000
0,00%
Brent Oil
0,00
0,00%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Science 37 Holdings Inc (SNCE)

  7. Science 37 Holdings Inc (SNCE) Notícias

SNCE

Science 37 (SNCE)

Science 37 Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNCE
DataHoraFonteTítuloCódigoCompanhia
14/01/202510:00GlobeNewswire Inc.Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access InnovationNASDAQ:SNCEScience 37 Holdings Inc
21/11/202410:00GlobeNewswire Inc.Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease TrialNASDAQ:SNCEScience 37 Holdings Inc
16/09/202409:00GlobeNewswire Inc.Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical TrialsNASDAQ:SNCEScience 37 Holdings Inc
06/08/202409:00GlobeNewswire Inc.Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NCNASDAQ:SNCEScience 37 Holdings Inc
18/07/202409:00GlobeNewswire Inc.Science 37 Enrolls 42% of Trial Cohort in 8 WeeksNASDAQ:SNCEScience 37 Holdings Inc
27/06/202410:41GlobeNewswire Inc.Science 37 Quickly Impacts Performance in Under-Enrolling Clinical TrialsNASDAQ:SNCEScience 37 Holdings Inc
12/06/202416:55GlobeNewswire Inc.CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical TrialNASDAQ:SNCEScience 37 Holdings Inc
12/06/202409:00GlobeNewswire Inc.Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical TrialNASDAQ:SNCEScience 37 Holdings Inc
13/05/202409:00GlobeNewswire Inc.Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and ComplianceNASDAQ:SNCEScience 37 Holdings Inc
09/05/202411:00GlobeNewswire Inc.Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”NASDAQ:SNCEScience 37 Holdings Inc
02/05/202409:00GlobeNewswire Inc.Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical TrialNASDAQ:SNCEScience 37 Holdings Inc
17/04/202409:00GlobeNewswire Inc.Science 37 Provides Fully Consented Patients to Sites to Supplement EnrollmentNASDAQ:SNCEScience 37 Holdings Inc
12/03/202407:45PR Newswire (US)eMed completes tender offer for all outstanding shares of Science 37NASDAQ:SNCEScience 37 Holdings Inc
04/03/202408:18Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SNCEScience 37 Holdings Inc
04/03/202408:01Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:SNCEScience 37 Holdings Inc
20/02/202401:16PR Newswire (US)Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law FirmNASDAQ:SNCEScience 37 Holdings Inc
12/02/202411:03Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SNCEScience 37 Holdings Inc
12/02/202410:16Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:SNCEScience 37 Holdings Inc
12/02/202409:45PR Newswire (US)eMed commences tender offer for Science 37NASDAQ:SNCEScience 37 Holdings Inc
09/02/202409:49Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:SNCEScience 37 Holdings Inc
09/02/202409:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNCEScience 37 Holdings Inc
30/01/202412:11Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:SNCEScience 37 Holdings Inc
12/12/202310:00GlobeNewswire Inc.Science 37 Receives Top Honors in Everest PEAK Matrix®NASDAQ:SNCEScience 37 Holdings Inc
07/12/202318:59GlobeNewswire Inc.Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNCEScience 37 Holdings Inc
05/12/202309:00GlobeNewswire Inc.Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023NASDAQ:SNCEScience 37 Holdings Inc
07/11/202308:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SNCEScience 37 Holdings Inc
07/11/202308:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNCEScience 37 Holdings Inc
27/10/202317:11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNCEScience 37 Holdings Inc
10/10/202317:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNCEScience 37 Holdings Inc
03/10/202317:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNCEScience 37 Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNCE

Seu Histórico Recente

BIT
Q00580
Leonteq Securities
BIT
UC5LVM
Unicredit Bank
BIT
UB2Y6A
UniCredit Bank
BIT
UC7V3Z
Unicredit Bank
BIT
SR2000
Invesco Russell 2000 UCI...
BIT
UB9P7H
Unicredit Bank
BIT
F39026
Vontobel Financial Produ...
BIT
UC7A84
Unicredit Bank
BIT
WNER
ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios